2'-O-PROPARGYL THYMIDINE-5'-MONOPHOSPHATE
RNA linking
ATOMN
C13 H17 N2 O9 P
DT
0
2004-12-17
2011-06-04
N
REL
376.256
T
2GT
Y
N
1Y9S
RCSB
P
P
0
1
N
N
N
10.749
4.067
5.377
2.787
0.324
-4.407
P
2GT
1
O1P
O
0
1
N
N
N
11.961
4.604
4.673
3.659
1.172
-5.286
OP1
2GT
2
O2P
O
0
1
N
N
N
10.921
3.350
6.620
1.198
0.588
-4.548
OP2
2GT
3
O5*
O
0
1
N
N
N
9.747
5.281
5.596
3.063
0.476
-2.819
O5'
2GT
4
C5*
C
0
1
N
N
N
9.479
6.145
4.523
2.282
-0.292
-1.921
C5'
2GT
5
C4*
C
0
1
N
N
R
8.428
7.143
4.925
2.725
0.023
-0.498
C4'
2GT
6
O4*
O
0
1
N
N
N
7.160
6.460
5.106
2.470
1.422
-0.246
O4'
2GT
7
C1*
C
0
1
N
N
R
6.438
7.082
6.161
1.373
1.543
0.675
C1'
2GT
8
N1
N
0
1
N
N
N
6.258
6.107
7.266
0.452
2.524
0.177
N1
2GT
9
C6
C
0
1
N
N
N
7.110
5.029
7.466
0.309
2.663
-1.199
C6
2GT
10
C2
C
0
1
N
N
N
5.200
6.336
8.099
-0.300
3.336
1.055
C2
2GT
11
O2
O
0
1
N
N
N
4.485
7.315
7.980
-0.225
3.269
2.283
O2
2GT
12
N3
N
0
1
N
N
N
5.027
5.398
9.095
-1.159
4.248
0.431
N3
2GT
13
C4
C
0
1
N
N
N
5.827
4.304
9.354
-1.338
4.427
-0.932
C4
2GT
14
O4
O
0
1
N
N
N
5.576
3.577
10.291
-2.112
5.251
-1.413
O4
2GT
15
C5
C
0
1
N
N
N
6.949
4.135
8.461
-0.514
3.537
-1.792
C5
2GT
16
C5M
C
0
1
N
N
N
7.884
2.988
8.690
-0.651
3.669
-3.275
C5M
2GT
17
C2*
C
0
1
N
N
R
7.268
8.288
6.624
0.748
0.163
0.786
C2'
2GT
18
O2*
O
0
1
N
N
N
6.939
9.362
5.745
0.137
-0.058
2.041
O2'
2GT
19
CB'
C
0
1
N
N
N
5.693
9.974
6.052
-0.332
-1.396
2.174
CB'
2GT
20
CC'
C
0
1
N
N
N
5.418
11.002
5.044
-0.958
-1.592
3.481
CC'
2GT
21
CD'
C
0
1
N
N
N
5.193
11.831
4.192
-1.472
-1.755
4.554
CD'
2GT
22
C3*
C
0
1
N
N
R
8.666
7.817
6.267
1.940
-0.742
0.560
C3'
2GT
23
O3*
O
0
1
N
N
N
9.613
8.876
6.221
2.742
-0.809
1.739
O3'
2GT
24
O3P
O
0
1
N
Y
N
2.921
-1.270
-4.647
OP3
2GT
25
2HOP
H
0
0
N
N
N
10.154
3.010
7.066
0.799
0.616
-5.443
HOP2
2GT
26
1H5*
H
0
1
N
N
N
9.199
5.590
3.597
1.229
-0.035
-2.051
H5'
2GT
27
2H5*
H
0
0
N
N
N
10.403
6.639
4.141
2.428
-1.352
-2.133
H5''
2GT
28
H4*
H
0
1
N
N
N
8.448
7.904
4.110
3.804
-0.139
-0.410
H4'
2GT
29
H1*
H
0
1
N
N
N
5.428
7.419
5.830
1.754
1.910
1.633
H1'
2GT
30
H6
H
0
1
N
N
N
7.969
4.873
6.792
0.928
1.995
-1.790
H6
2GT
31
HN3
H
0
1
N
N
N
4.221
5.527
9.706
-1.709
4.843
1.045
HN3
2GT
32
1H5M
H
0
1
N
N
N
8.912
3.410
8.785
-1.057
2.748
-3.690
H71
2GT
33
2H5M
H
0
1
N
N
N
7.751
2.248
9.514
0.324
3.866
-3.719
H72
2GT
34
3H5M
H
0
1
N
N
N
7.948
2.415
7.735
-1.320
4.497
-3.510
H73
2GT
35
H2*
H
0
1
N
N
N
7.130
8.603
7.685
-0.000
0.004
-0.000
H2'
2GT
36
1HB'
H
0
0
N
N
N
5.658
10.375
7.092
-1.036
-1.599
1.361
HB'1
2GT
37
2HB'
H
0
0
N
N
N
4.864
9.234
6.145
0.525
-2.065
2.052
HB'2
2GT
38
HD'
H
0
1
N
N
N
4.990
12.578
3.424
-1.928
-1.900
5.505
HD'
2GT
39
H3*
H
0
1
N
N
N
9.123
7.137
7.023
1.675
-1.764
0.277
H3'
2GT
40
H3T
H
0
0
N
Y
N
9.762
9.297
7.060
3.447
-0.153
1.628
HO3'
2GT
41
3HOP
H
0
0
N
N
N
-0.767
-0.340
0.446
2.886
-1.617
-5.563
HOP3
2GT
42
doub
N
N
1
sing
N
N
2
sing
N
N
3
sing
N
N
4
sing
N
N
5
sing
N
N
6
sing
N
N
7
sing
N
N
8
sing
N
N
9
sing
N
N
10
sing
N
N
11
sing
N
N
12
sing
N
N
13
sing
N
N
14
sing
N
N
15
sing
N
N
16
sing
N
N
17
sing
N
N
18
doub
N
N
19
sing
N
N
20
doub
N
N
21
sing
N
N
22
sing
N
N
23
sing
N
N
24
doub
N
N
25
sing
N
N
26
sing
N
N
27
sing
N
N
28
sing
N
N
29
sing
N
N
30
sing
N
N
31
sing
N
N
32
sing
N
N
33
sing
N
N
34
sing
N
N
35
sing
N
N
36
sing
N
N
37
trip
N
N
38
sing
N
N
39
sing
N
N
40
sing
N
N
41
sing
N
N
42
sing
N
N
43
O=C1NC(=O)N(C=C1C)C2OC(C(O)C2OCC#C)COP(=O)(O)O
CC1=CN([C@@H]2O[C@H](CO[P](O)(O)=O)[C@@H](O)[C@H]2OCC#C)C(=O)NC1=O
CC1=CN([CH]2O[CH](CO[P](O)(O)=O)[CH](O)[CH]2OCC#C)C(=O)NC1=O
CC1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)OCC#C
CC1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)O)O)OCC#C
InChI=1S/C13H17N2O9P/c1-3-4-22-10-9(16)8(6-23-25(19,20)21)24-12(10)15-5-7(2)11(17)14-13(15)18/h1,5,8-10,12,16H,4,6H2,2H3,(H,14,17,18)(H2,19,20,21)/t8-,9-,10-,12-/m1/s1
HARKMJGNXJUASR-DNRKLUKYSA-N
5-methyl-2'-O-prop-2-yn-1-yluridine 5'-(dihydrogen phosphate)
[(2R,3R,4R,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)-4-prop-2-ynoxy-oxolan-2-yl]methyl dihydrogen phosphate
RCSB
RCSB
RCSB